| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1630172A2 A method for identification, isolation and production of antigens to a specific phathogen |
| 03/01/2006 | EP1630171A1 Streptavidin binding peptides |
| 03/01/2006 | EP1629107A2 Cyclodextrin affinity purification |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629102A2 Modified starch, uses, methods for production thereof |
| 03/01/2006 | EP1629095A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/01/2006 | EP1629086A2 POLYNUCLEOTIDES ENCODING NOVEL GUANYLATE BINDING PROTEINS (GBP'S) |
| 03/01/2006 | EP1628680A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/01/2006 | EP1563084A4 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | EP1341899B1 Bacterial host strains |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1141252B1 Human delta 5-desaturase gene and uses thereof |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1097228B1 Method of making proteins in transformed yeast cells |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0994191B1 System for expressing hyperthermostable protease |
| 03/01/2006 | EP0956506B1 Treatment and diagnosis of cancer |
| 03/01/2006 | EP0941315B1 Fusion proteins containing stress proteins for inducing immune responses |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0786009B1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | EP0677105B1 Allergenic proteins and peptides from dog dander and uses therefor |
| 03/01/2006 | CN1742089A Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 03/01/2006 | CN1742088A Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | CN1742078A Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
| 03/01/2006 | CN1741741A Composition and method for treating lupus nephritis |
| 03/01/2006 | CN1739790A Peptidoglycan immunopotentiator and its production process |
| 03/01/2006 | CN1243830C Novel mouse CXC chemotactic receptor |
| 03/01/2006 | CN1243771C Novel alginate monoclonal antibody and its preparation method and use |
| 02/28/2006 | US7005814 Motor control apparatus having current supply phase correction |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005506 Processing albumin via grinding substance to flour, alkaline and protease extractions, heating, precipitation, neutralization and recovery |
| 02/28/2006 | US7005501 Interleukins; muteins; diagnostic kits |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005299 gene trap vector containing expression unit of internal ribosome binding site coupled to heterologous gene sequence (antibiotic resistance), for insertion/transformation within mouse embryonic stem cell; homologous recombination |
| 02/28/2006 | US7005289 Polynucleotide derived from fungal source which comprises a nucleotide sequence encoding an enzyme having beta-glucosidase activity |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005283 taxoid oxygenases; for production of paclitaxel; plant cells |
| 02/28/2006 | US7005276 missense mutagenesis; blood testing; host cells; kits |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7005270 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 02/28/2006 | CA2180346C Herpesvirus pre-(viral dna replication) enveloped particles |
| 02/23/2006 | WO2006020868A2 Intracellular production of a nuclease |
| 02/23/2006 | WO2006020849A2 Mutant interleukin-15 polypeptides |
| 02/23/2006 | WO2006020594A2 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/23/2006 | WO2006020541A2 Methods for synthesizing polypeptides |
| 02/23/2006 | WO2006020372A2 Enzymatic modification of glycopeptides |
| 02/23/2006 | WO2006019876A2 Production of fusion proteins by cell-free protein synthesis |
| 02/23/2006 | WO2006019194A1 Cap-independent rna translation efficiency controller and utilization of the same |
| 02/23/2006 | WO2006019192A1 POLYPEPTIDE HAVING ACTIVITY OF UNSATURATING ω3-FATTY ACID, POLYNUCLEOTIDE CODING FOR THE POLYPEPTIDE AND USE THEREOF |
| 02/23/2006 | WO2006017961A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 02/23/2006 | WO2005116235A9 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 02/23/2006 | WO2004045553A3 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | US20060041947 Nessie nucleic acids, polypeptides and mutations, and methods of use thereof |
| 02/23/2006 | US20060041111 Dock 3 tumor suppressor gene |
| 02/23/2006 | US20060040883 Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040872 Calcium channel inhibitor |
| 02/23/2006 | US20060040862 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 02/23/2006 | US20060040373 Papermaking, food, agriculture; genetic engineered polynucleotide; degradation of plant cell wall components; decomposition of plants and fruits |
| 02/23/2006 | US20060040372 GANP protein |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040370 Purified thermostable pyrococcus furiosus dna polymerase i |
| 02/23/2006 | US20060040363 Human antibodies derived from immunized xenomice |
| 02/23/2006 | US20060040362 Recombinant human Mannan-Building Proteins |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040357 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 02/23/2006 | US20060040356 Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
| 02/23/2006 | US20060040355 Mutated Tn5 transposase proteins and the use thereof |
| 02/23/2006 | US20060040354 Novel polyadenylation signal for use in expression vectors |
| 02/23/2006 | US20060040353 Production of galactosylated glycoproteins in lower eukaryotes |
| 02/23/2006 | US20060040352 Expression of mammalian proteins in Pseudomonas fluorescens |
| 02/23/2006 | US20060040351 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040350 DNA which encodes the receptor, a transformed cell expressing the receptor, for producing the receptor, for identifying an agonist, antagonist, or allosteric modulator for glutamic acid |
| 02/23/2006 | US20060040349 Thermophilic hydrophobin proteins and applications for surface modification |
| 02/23/2006 | US20060040348 Methods for producing and purifying recombinant alpha-L-iduronidase |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040346 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 02/23/2006 | US20060040345 Deglycosylated enzymes for conjugates |
| 02/23/2006 | US20060040343 Identification of 3-Ketosteroid 9-Alfa-hydroxylase genes and microorganisms blocked in 3-Ketosteroid 9-Alfa-hydroxylase activity |
| 02/23/2006 | US20060040342 sequences that regulate the expression of genes that are differentially expressed in a native fungus exhibiting a pelleted morphology relative to a filamented morphology |
| 02/23/2006 | US20060040328 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis |
| 02/23/2006 | US20060040325 Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| 02/23/2006 | US20060040323 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040289 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040285 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 02/23/2006 | US20060040279 DNA chips used for bioprocess control |
| 02/23/2006 | US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |